Journal
AUSTRALASIAN PHYSICAL & ENGINEERING SCIENCES IN MEDICINE
Volume 37, Issue 4, Pages 753-761Publisher
SPRINGER
DOI: 10.1007/s13246-014-0293-6
Keywords
Radiotherapy; Dosimetry; Absorbed dose; Protocol; TRS-398; Megavoltage calibration
Categories
Funding
- National Cancer Institute, NIH, DHHS [CA 10953]
Ask authors/readers for more resources
The Australian Radiation Protection and Nuclear Safety Agency (ARPANSA) maintains the Australian primary standard of absorbed dose. Until recently, the standard was used to calibrate ionisation chambers only in Co-60 gamma rays. These chambers are then used by radiotherapy clinics to determine linac output, using a correction factor (k (Q) ) to take into account the different spectra of Co-60 and the linac. Over the period 2010-2013, ARPANSA adapted the primary standard to work in megavoltage linac beams, and has developed a calibration service at three photon beams (6, 10 and 18 MV) from an Elekta Synergy linac. We describe the details of the new calibration service, the method validation and the use of the new calibration factors with the International Atomic Energy Agency's TRS-398 dosimetry Code of Practice. The expected changes in absorbed dose measurements in the clinic when shifting from Co-60 to the direct calibration are determined. For a Farmer chamber (model 2571), the measured chamber calibration coefficient is expected to be reduced by 0.4, 1.0 and 1.1 % respectively for these three beams when compared to the factor derived from Co-60. These results are in overall agreement with international absorbed dose standards and calculations by Muir and Rogers in 2010 of k (Q) factors using Monte Carlo techniques. The reasons for and against moving to the new service are discussed in the light of the requirements of clinical dosimetry.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available